BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 9547670)

  • 1. IL-4R expression in AIDS-KS cells and response to rhIL-4 and IL-4 toxin (DAB389-IL-4).
    Cai J; Zheng T; Murphy J; Waters CA; Lin GY; Gill PS
    Invest New Drugs; 1997; 15(4):279-87. PubMed ID: 9547670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of AIDS-associated Kaposi's sarcoma cell growth by DAB389-interleukin 6.
    Masood R; Lunardi-Iskandar Y; Jean LF; Murphy JR; Waters C; Gallo RC; Gill P
    AIDS Res Hum Retroviruses; 1994 Aug; 10(8):969-75. PubMed ID: 7811548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-4 receptor expression on AIDS-associated Kaposi's sarcoma cells and their targeting by a chimeric protein comprised of circularly permuted interleukin-4 and Pseudomonas exotoxin.
    Husain SR; Gill P; Kreitman RJ; Pastan I; Puri RK
    Mol Med; 1997 May; 3(5):327-38. PubMed ID: 9205948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AIDS-associated Kaposi's sarcoma (KS) cells express oncostatin M (OM)-specific receptor but not leukemia inhibitory factor/OM receptor or interleukin-6 receptor. Complete block of OM-induced KS cell growth and OM binding by anti-gp130 antibodies.
    Murakami-Mori K; Taga T; Kishimoto T; Nakamura S
    J Clin Invest; 1995 Sep; 96(3):1319-27. PubMed ID: 7657807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-4 receptor expression in vivo on human AIDS-related Kaposi's sarcoma.
    Varricchio F; Husain SR; Leland P; Gill P; Puri RK
    Oncol Res; 1997; 9(9):495-503. PubMed ID: 9495455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential sensitivity of human myeloma cell lines and normal bone marrow colony forming cells to a recombinant diphtheria toxin-interleukin 6 fusion protein.
    Chadwick DE; Jean LF; Jamal N; Messner HA; Murphy JR; Minden MD
    Br J Haematol; 1993 Sep; 85(1):25-36. PubMed ID: 8251407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Receptor for interleukin 13 on AIDS-associated Kaposi's sarcoma cells serves as a new target for a potent Pseudomonas exotoxin-based chimeric toxin protein.
    Husain SR; Obiri NI; Gill P; Zheng T; Pastan I; Debinski W; Puri RK
    Clin Cancer Res; 1997 Feb; 3(2):151-6. PubMed ID: 9815666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of oncostatin M secretion by human retrovirus-infected cells with potent growth stimulation of cultured spindle cells from AIDS-Kaposi's sarcoma.
    Radka SF; Nakamura S; Sakurada S; Salahuddin SZ
    J Immunol; 1993 Jun; 150(11):5195-201. PubMed ID: 8098726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endogenous basic fibroblast growth factor is essential for cyclin E-CDK2 activity in multiple external cytokine-induced proliferation of AIDS-associated Kaposi's sarcoma cells: dual control of AIDS-associated Kaposi's sarcoma cell growth and cyclin E-CDK2 activity by endogenous and external signals.
    Murakami-Mori K; Mori S; Nakamura S
    J Immunol; 1998 Aug; 161(4):1694-704. PubMed ID: 9712033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of interleukin-1 and interleukin-1 receptor antagonist in AIDS-Kaposi's sarcoma.
    Louie S; Cai J; Law R; Lin G; Lunardi-Iskandar Y; Jung B; Masood R; Gill P
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Apr; 8(5):455-60. PubMed ID: 7697441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-4 receptor expression by human B cells: functional analysis with a human interleukin-4 toxin, DAB389IL-4.
    Jabara HH; Vercelli D; Schneider LC; Williams DP; Genbauffe FS; Poisson LR; Waters CA; Geha RS
    J Allergy Clin Immunol; 1995 Apr; 95(4):893-900. PubMed ID: 7722171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The soluble form of the IL-6 receptor (sIL-6R alpha) is a potent growth factor for AIDS-associated Kaposi's sarcoma (KS) cells; the soluble form of gp130 is antagonistic for sIL-6R alpha-induced AIDS-KS cell growth.
    Murakami-Mori K; Taga T; Kishimoto T; Nakamura S
    Int Immunol; 1996 Apr; 8(4):595-602. PubMed ID: 8722639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncostatin-M is an autocrine growth factor in Kaposi's sarcoma.
    Cai J; Gill PS; Masood R; Chandrasoma P; Jung B; Law RE; Radka SF
    Am J Pathol; 1994 Jul; 145(1):74-9. PubMed ID: 8030759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of high-affinity interleukin 4 receptors on murine sarcoma cells and receptor-mediated cytotoxicity of tumor cells to chimeric protein between interleukin 4 and Pseudomonas exotoxin.
    Puri RK; Ogata M; Leland P; Feldman GM; FitzGerald D; Pastan I
    Cancer Res; 1991 Jun; 51(11):3011-7. PubMed ID: 2032239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of high affinity interleukin-4 receptors on human renal cell carcinoma cells and inhibition of tumor cell growth in vitro by interleukin-4.
    Obiri NI; Hillman GG; Haas GP; Sud S; Puri RK
    J Clin Invest; 1993 Jan; 91(1):88-93. PubMed ID: 8423237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of protein synthesis in small cell lung cancer cells induced by the diphtheria toxin-related fusion protein DAB389 GRP.
    vanderSpek JC; Sutherland JA; Zeng H; Battey JF; Jensen RT; Murphy JR
    Cancer Res; 1997 Jan; 57(2):290-4. PubMed ID: 9000570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammatory cytokines induce the expression of basic fibroblast growth factor (bFGF) isoforms required for the growth of Kaposi's sarcoma and endothelial cells through the activation of AP-1 response elements in the bFGF promoter.
    Faris M; Ensoli B; Kokot N; Nel AE
    AIDS; 1998 Jan; 12(1):19-27. PubMed ID: 9456251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oncostatin M as a potent mitogen for AIDS-Kaposi's sarcoma-derived cells.
    Miles SA; Martínez-Maza O; Rezai A; Magpantay L; Kishimoto T; Nakamura S; Radka SF; Linsley PS
    Science; 1992 Mar; 255(5050):1432-4. PubMed ID: 1542793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and cytokine regulation of glucocorticoid receptors in Kaposi's sarcoma.
    Guo WX; Antakly T; Cadotte M; Kachra Z; Kunkel L; Masood R; Gill P
    Am J Pathol; 1996 Jun; 148(6):1999-2008. PubMed ID: 8669484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-13 fusion cytotoxin as a potent targeted agent for AIDS-Kaposi's sarcoma xenograft.
    Husain SR; Puri RK
    Blood; 2000 Jun; 95(11):3506-13. PubMed ID: 10828036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.